Form 4: Hims & Hers Health Chief Legal Officer Reports Stock Transactions

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Summary

• On September 13, 2024, Soleil Boughton acquired 43,210 shares of Class A Common Stock.
• On the same date, 23,715 shares were withheld by the issuer to cover tax obligations related to the vesting of Restricted Stock Units (RSUs).
• Boughton also disposed of 2,339 shares of Class A Common Stock on September 17, 2024, at a price of $16.50 per share.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 10, 2023.
• Several transactions involved the vesting of RSUs, each representing a contingent right to receive one share of Class A Common Stock.
• The RSUs vest in quarterly installments over a 4-year period, with various vesting start dates.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. These transactions are subject to regulations to prevent insider trading and ensure transparency.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The use of Rule 10b5-1 trading plans is a common method for corporate insiders to sell shares without being accused of acting on non-public information.
• The vesting schedules of the Restricted Stock Units (RSUs) are typical, with quarterly vesting over a 4-year period being a standard practice for employee equity compensation.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by an insider.
• The withholding of shares for tax obligations affects the executive's net compensation.

Key Dates